# Empire Petroleum Corp: financial statements, quarterly

EP · NYSE · CIK 887396 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ep.md) · [Financials](/companies/ep/financials.md) · [Filings](/companies/ep/filings.md) · [Insiders](/companies/ep/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ep/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.1](/filings/0001072613-24-000864.md) | [11.2 d](/filings/0001072613-25-000246.md) | [9.4](/filings/0001072613-25-000399.md) | [12.8](/filings/0001072613-25-000553.md) | [11.4](/filings/0001104659-25-112537.md) | [10.1 d](/filings/0001104659-26-027675.md) | [9.0](/filings/0001104659-26-061187.md) | [8.8](/filings/0001104659-26-097162.md) | [9.4](/filings/0001104659-25-112537.md) | [7.1 d](/filings/0001104659-26-027675.md) | [5.1](/filings/0001104659-26-061187.md) | [9.5](/filings/0001104659-26-097162.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(2.6)](/filings/0001072613-24-000864.md) | [(4.5) d](/filings/0001072613-25-000246.md) | [(4.4)](/filings/0001072613-25-000399.md) | [(1.9)](/filings/0001072613-25-000553.md) | [(3.4)](/filings/0001104659-25-112537.md) | [(3.9) d](/filings/0001104659-26-027675.md) | [(4.0)](/filings/0001104659-26-061187.md) | [(4.9)](/filings/0001104659-26-097162.md) | [(3.5)](/filings/0001104659-25-112537.md) | [(58.9) d](/filings/0001104659-26-027675.md) | [(5.6)](/filings/0001104659-26-061187.md) | [(1.5)](/filings/0001104659-26-097162.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [0.2](/filings/0001104659-25-112537.md) | [0.3 d](/filings/0001104659-26-027675.md) | [0.3](/filings/0001104659-26-061187.md) | [0.3](/filings/0001104659-26-097162.md) | [0.4](/filings/0001104659-25-112537.md) | [0.5 d](/filings/0001104659-26-027675.md) | [0.5](/filings/0001104659-26-061187.md) | [0.3](/filings/0001104659-26-097162.md) |
| Income tax | $m | [(0.1)](/filings/0001072613-24-000864.md) | [0.0 d](/filings/0001072613-25-000246.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(2.7)](/filings/0001072613-24-000864.md) | [(4.8) d](/filings/0001072613-25-000246.md) | [(4.0)](/filings/0001104659-25-112537.md) | [(4.4)](/filings/0001104659-25-112537.md) | [(3.6)](/filings/0001104659-25-112537.md) | [(4.2) d](/filings/0001104659-26-027675.md) | [(4.2)](/filings/0001104659-26-097162.md) | [(5.1)](/filings/0001104659-26-097162.md) | [(3.8)](/filings/0001104659-25-112537.md) | [(59.0) d](/filings/0001104659-26-027675.md) | [(6.6)](/filings/0001104659-26-097162.md) | [(1.9)](/filings/0001104659-26-097162.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001072613-24-000864.md) | not reported | [(0.15)](/filings/0001072613-25-000399.md) | [(0.15)](/filings/0001072613-25-000553.md) | [(0.12)](/filings/0001104659-25-112537.md) | not reported | [(0.12)](/filings/0001104659-26-061187.md) | [(0.15)](/filings/0001104659-26-097162.md) | [(0.11)](/filings/0001104659-25-112537.md) | not reported | [(0.18)](/filings/0001104659-26-061187.md) | [(0.05)](/filings/0001104659-26-097162.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0001072613-24-000864.md) | not reported | [(0.15)](/filings/0001072613-25-000399.md) | [(0.15)](/filings/0001072613-25-000553.md) | [(0.12)](/filings/0001104659-25-112537.md) | not reported | [(0.12)](/filings/0001104659-26-061187.md) | [(0.15)](/filings/0001104659-26-097162.md) | [(0.11)](/filings/0001104659-25-112537.md) | not reported | [(0.18)](/filings/0001104659-26-061187.md) | [(0.05)](/filings/0001104659-26-097162.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.0](/filings/0001072613-23-000570.md) | [7.8](/filings/0001072613-25-000246.md) | [3.5](/filings/0001072613-24-000499.md) | [9.3](/filings/0001072613-24-000631.md) | [3.1](/filings/0001072613-24-000864.md) | [2.3](/filings/0001104659-26-027675.md) | [1.1](/filings/0001072613-25-000399.md) | [2.3](/filings/0001072613-25-000553.md) | [4.6](/filings/0001104659-25-112537.md) | [1.2](/filings/0001104659-26-097162.md) | [8.8](/filings/0001104659-26-061187.md) | [3.1](/filings/0001104659-26-097162.md) |
| Current assets | $m | [20.4](/filings/0001072613-23-000570.md) | [18.7](/filings/0001072613-25-000246.md) | [13.8](/filings/0001072613-24-000499.md) | [20.3](/filings/0001072613-24-000631.md) | [11.7](/filings/0001072613-24-000864.md) | [12.4](/filings/0001104659-26-027675.md) | [11.6](/filings/0001072613-25-000399.md) | [14.5](/filings/0001072613-25-000553.md) | [14.7](/filings/0001104659-25-112537.md) | [8.2](/filings/0001104659-26-097162.md) | [17.3](/filings/0001104659-26-061187.md) | [12.0](/filings/0001104659-26-097162.md) |
| Total assets | $m | [76.3](/filings/0001072613-23-000570.md) | [92.6](/filings/0001072613-25-000246.md) | [100](/filings/0001072613-24-000499.md) | [120](/filings/0001072613-24-000631.md) | [121](/filings/0001072613-24-000864.md) | [124](/filings/0001104659-26-027675.md) | [124](/filings/0001072613-25-000399.md) | [125](/filings/0001072613-25-000553.md) | [123](/filings/0001104659-25-112537.md) | [65.9](/filings/0001104659-26-097162.md) | [78.0](/filings/0001104659-26-061187.md) | [81.1](/filings/0001104659-26-097162.md) |
| Current liabilities | $m | [18.9](/filings/0001072613-23-000570.md) | [25.0](/filings/0001072613-25-000246.md) | [27.0](/filings/0001072613-24-000499.md) | [23.8](/filings/0001072613-24-000631.md) | [27.0](/filings/0001072613-24-000864.md) | [21.3](/filings/0001104659-26-027675.md) | [24.0](/filings/0001072613-25-000399.md) | [26.2](/filings/0001072613-25-000553.md) | [23.3](/filings/0001104659-25-112537.md) | [24.3](/filings/0001104659-26-097162.md) | [29.3](/filings/0001104659-26-061187.md) | [28.3](/filings/0001104659-26-097162.md) |
| Total liabilities | $m | [57.4](/filings/0001072613-23-000570.md) | [57.7](/filings/0001072613-25-000246.md) | [68.4](/filings/0001072613-24-000499.md) | [61.3](/filings/0001072613-24-000631.md) | [64.7](/filings/0001072613-24-000864.md) | [61.1](/filings/0001104659-26-027675.md) | [64.6](/filings/0001072613-25-000399.md) | [70.2](/filings/0001072613-25-000553.md) | [69.3](/filings/0001104659-25-112537.md) | [70.5](/filings/0001104659-26-097162.md) | [74.3](/filings/0001104659-26-061187.md) | [73.8](/filings/0001104659-26-097162.md) |
| Long-term debt | $m | [0.1](/filings/0001072613-23-000570.md) | [4.6](/filings/0001072613-25-000246.md) | [8.5](/filings/0001072613-24-000499.md) | [8.5](/filings/0001072613-24-000631.md) | [8.5](/filings/0001072613-24-000864.md) | [11.3](/filings/0001104659-25-112537.md) | [11.6](/filings/0001072613-25-000399.md) | [14.6](/filings/0001072613-25-000553.md) | [15.2](/filings/0001104659-25-112537.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [4.5](/filings/0001072613-23-000570.md) | [0.0](/filings/0001072613-25-000246.md) | [0.5](/filings/0001072613-24-000499.md) | [0.3](/filings/0001072613-24-000631.md) | [0.2](/filings/0001072613-24-000864.md) | [0.1](/filings/0001104659-26-027675.md) | [0.7](/filings/0001072613-25-000399.md) | [0.5](/filings/0001072613-25-000553.md) | [0.4](/filings/0001104659-25-112537.md) | [0.6](/filings/0001104659-26-097162.md) | [1.0](/filings/0001104659-26-061187.md) | [1.6](/filings/0001104659-26-097162.md) |
| Shareholders' equity | $m | [18.8](/filings/0001072613-24-000864.md) | [35.0](/filings/0001104659-26-027675.md) | [31.7](/filings/0001104659-25-112537.md) | [58.7](/filings/0001104659-25-112537.md) | [56.5](/filings/0001104659-25-112537.md) | [62.8](/filings/0001104659-26-097162.md) | [59.1](/filings/0001104659-26-097162.md) | [54.5](/filings/0001104659-26-097162.md) | [53.7](/filings/0001104659-25-112537.md) | [(4.6)](/filings/0001104659-26-097162.md) | [3.7](/filings/0001104659-26-097162.md) | [7.3](/filings/0001104659-26-097162.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.0 d](/filings/0001072613-24-000864.md) | [(3.9) d](/filings/0001072613-25-000246.md) | [3.9](/filings/0001072613-25-000399.md) | [(1.8) d](/filings/0001072613-25-000553.md) | [12.8 d](/filings/0001104659-25-112537.md) | [(8.8) d](/filings/0001104659-26-027675.md) | [1.6](/filings/0001104659-26-061187.md) | [(3.1) d](/filings/0001104659-26-097162.md) | [0.3 d](/filings/0001104659-25-112537.md) | [(2.8) d](/filings/0001104659-26-027675.md) | [(1.0)](/filings/0001104659-26-061187.md) | [(2.8) d](/filings/0001104659-26-097162.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001072613-23-000570.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [0.0](/filings/0001072613-23-000570.md) | [0.0](/filings/0001072613-24-000499.md) | [0.0](/filings/0001072613-24-000631.md) | [0.0](/filings/0001072613-24-000864.md) | [0.0](/filings/0001072613-25-000399.md) | [29.8](/filings/0001072613-25-000553.md) | [0.0](/filings/0001104659-25-112537.md) | [0.0](/filings/0001104659-26-061187.md) | [0.0](/filings/0001104659-26-097162.md) | [0.0](/filings/0001104659-25-112537.md) | [0.0](/filings/0001104659-26-061187.md) | [0.0](/filings/0001104659-26-097162.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,577,341 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-097162.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.